View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of...

BlackLine, Inc. Announces Proposed Private Offering of $500,000,000 of Convertible Senior Notes LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced that it intends to offer, subject to market conditions and other factors, $500,000,000 aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). BlackLine also intends to grant the initial purchaser of the notes a 13-day option to purchase...

Tejas Networks Ltd: 5 directors

Seven Directors at Tejas Networks Ltd sold 17,657 shares at between 1,145.102INR and 1,224.455INR. The significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...

 PRESS RELEASE

BW Energy: Invitation to Q1 2024 results presentation 24 May

BW Energy: Invitation to Q1 2024 results presentation 24 May BW Energy: Invitation to Q1 2024 results presentation 24 May BW Energy will release its first quarter 2024 results on Friday 24 May at 07:30 CEST. A conference call followed by Q&A will be hosted by CEO Carl K. Arnet, CFO Knut R. Sæthre and COO Lin G. Espey the same day at 14:00 CEST. You can follow the presentation via webcast with supporting slides, available on: Viewer Registration • Q1 2024 (webcast.no)   Call-in information Participants dial in numbers: DK: SE: NO: UK: 9 US: Singapore: 65...

 PRESS RELEASE

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Lands...

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024 WINSTON-SALEM, N.C., May 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), will host a virtual KOL event on Tuesday, May 28, 2024 at 8:00 AM ET, featuring Steven G. Coca, DO, MS (Icahn School of Medicine at Mount Sinai) and Arnold L. Silva, MD, PhD (University of Arizon...

 PRESS RELEASE

Planet Fitness’ High School Summer Pass™ Returns; Teens Work Out Free ...

Planet Fitness’ High School Summer Pass™ Returns; Teens Work Out Free June 1 – August 31 New study finds that ninety per cent of Canadian teens believe physical activity can positively impact their lives and boost mental health1 TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- , one of the largest and fastest-growing franchisors and operators of fitness centers with more members than any other fitness brand, announces the return of its High School Summer Pass™ program, inviting high school teens ages 14 – 192 to work out for free at any of its 2,500+ Planet Fitness locations across the U.S. and...

 PRESS RELEASE

BioXcel Therapeutics Announces Oral and Poster Presentations at the 20...

BioXcel Therapeutics Announces Oral and Poster Presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting NEW HAVEN, Conn., May 21, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that Rob Risinger, M.D., Chief Medical Officer of Neuroscience, will deliver oral and poster presentations at the 2024 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting. The meeting will ...

 PRESS RELEASE

Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease...

Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits colitis disease progression and colon inflammation, lowers inflammatory mucosal cytokines, and reduces expression of IBD-associated genes in a colitis model Initiation of MRT-6160 Phase 1 SAD/MAD study anticipated in mid-year 2024 with Phase 1 clinical data expected in Q1 2025 Poster presentation today at 12:30 pm ET  BOSTON, May 21, 2024 (GLOBE NEWSWIRE) --  (Nasd...

 PRESS RELEASE

LAVA Provides Business Updates and Reports First Quarter 2024 Financia...

LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024Received $7.0 million clinical development milestone from Pfizer for PF-08046052 (formerly LAVA-1223) in Phase 1LAVA-1266 on track for Q2 2024 IND submissionStrong balance sheet with cash of $94.6 million supports runway into 2026 UTRECHT, The Netherlands and PHILADELPHIA, May 21, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: LVTX, “LAVA,” “the Company”), a clinical-stage immuno-oncolog...

 PRESS RELEASE

KANZHUN LIMITED Announces First Quarter 2024 Financial Results

KANZHUN LIMITED Announces First Quarter 2024 Financial Results BEIJING, May 21, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced its unaudited financial results for the quarter ended March 31, 2024. First Quarter 2024 Highlights Revenues for the first quarter of 2024 were RMB1,703.8 million (US$236.0 million), an increase of 33.4% from RMB1,277.5 million for the same quarter of 2023.Calculated cash billings1 for the first quarter of 2024 were RMB2,050.7 million (US$284.0 mi...

 PRESS RELEASE

ECARX-Powered Lynk & Co. 07 EM-P Sedan Began Deliveries in China

ECARX-Powered Lynk & Co. 07 EM-P Sedan Began Deliveries in China SHANGHAI, China, May 21, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, today congratulated Lynk & Co on the first deliveries of the Lynk & Co 07 EM-P sedan, which is integrated with ECARX’s full-stack solution for digital cockpit and ADAS including Antora® 1000 Pro, Skyland Pro, and Flyme Auto. The EM-P 07 began deliveries on May 17, 2024. The Lynk & Co 07 EM-P was officially unveiled at the Beijing Auto Show 2024 in April, where it attracted i...

 PRESS RELEASE

GXO Deploys Innovative Approach to Providing Workforce Flexibility

GXO Deploys Innovative Approach to Providing Workforce Flexibility Program provides on-demand employment opportunities for students, caregivers, retirees and others who value ability to make their own schedules GXO leads industry with successful pilot across the U.S., increasing workforce flexibility, raising engagement and paving way for wider rollout GREENWICH, Conn., May 21, 2024 (GLOBE NEWSWIRE) --   (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has completed a successful pilot of a workforce flexibility platform that...

 PRESS RELEASE

ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Ebl...

ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference Translational data presented during a late-breaker poster session from a head-to-head study of eblasakimab and dupilumab in a human tissue model of COPD indicates that eblasakimab performed better than dupilumab in improving airway function and enhancing bronchodilation at the same concentrations Results support further investigation of eblasakimab as a potential therapeutic option for COPD with potentially more effective blockade of Type-2 mediate...

 PRESS RELEASE

PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal P...

PyroGenesis Announces Receipt of $1.5 Million as Settlement in Legal Proceedings MONTREAL, May 21, 2024 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. () (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY), a high-tech company (the “Company” or “PyroGenesis”) that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions which are geared to reduce greenhouse gases (GHG) and address environmental pollutants, is pleased to announce that its wholly-owned subsidiary Pyro Green-Gas Inc. and certain related persons (collectively, the “PGG Parties”) have settled all o...

 PRESS RELEASE

American Shared Hospital Services Announces Annual Shareholder Meeting...

American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Tuesday, June 25, 2024 Meeting Will be Held at The Hilton Hotel, San Francisco, CA SAN FRANCISCO, May 21, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that its Annual Meeting of Shareholders will be held on Tuesday, June 25, 2024, at 9:00 a.m. PT. The Annual Meeting will be an in-person meeting. For tho...

 PRESS RELEASE

Balchem Corporation to Attend the Deutsche Bank Global Consumer Confer...

Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024 MONTVALE, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024. Ted Harris, Chairman of the Board, President and Chief Executive Officer, and Martin Bengtsson, Chief Financial Officer will attend the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients ...

 PRESS RELEASE

BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Gras...

BLM and DOGAMI Agree to a Joint Reclamation Bond for the Proposed Grassy Mountain Gold and Silver Mine WINNEMUCCA, Nev., May 21, 2024 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) is pleased to announce its proposed Grassy Mountain gold mine will have the benefit of a joint reclamation bond between the Oregon Department of Geology and Mineral Industries (the “DOGAMI”) and the Bureau of Land Management (“BLM”). The two agencies have executed a Memorandum of Understanding (“MOU”) which ensures that Paramount will not be required to post ...

 PRESS RELEASE

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Dire...

Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors DUBLIN, Ireland, May 21, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today the appointment of Naseem Amin, M.D. to its board of directors, effective May 17, 2024. Dr. Amin, a highly successful executive who brings global industry and leadership experience to Avadel, currently serves as Chief Executive Officer of Orphalan SA. “On behalf of the entire Avadel team, we are excited to welcome Dr. Amin to...

 PRESS RELEASE

Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional...

Tecnoglass to Attend the B. Riley Securities 24th Annual Institutional Investor Conference Miami, FL, May 21, 2024 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that the Company will attend the B. Riley Securities 24th Annual Institutional Investor Conference in Beverly Hills, CA on Thursday, May 23, 2024. About Tecnoglass Tecnoglass Inc. is a leading producer of high-end aluminum and vinyl windo...

 PRESS RELEASE

AutoZone 3rd Quarter Total Company Same Store Sales Increase 0.9%; Dom...

AutoZone 3rd Quarter Total Company Same Store Sales Increase 0.9%; Domestic Same Store Sales were flat; EPS Increases to $36.69 MEMPHIS, Tenn., May 21, 2024 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE: AZO) today reported net sales of $4.2 billion for its third quarter (12 weeks) ended May 4, 2024, an increase of 3.5% from the third quarter of fiscal 2023 (12 weeks). Same store sales, or sales for our domestic and international stores open at least one year, are as follows:        Constant Currency 12 Weeks 12 Weeks*    Domestic0.0% 0.0%International18.1% 9.3%Total Company1.9% 0.9%* Exclude...

 PRESS RELEASE

CI Financial Reports Total Assets of $467.9 Billion for April 2024

TORONTO--(BUSINESS WIRE)-- . (“CI”) (TSX: CIX) today reported preliminary total assets of $467.9 billion as at April 30, 2024, consisting of asset management assets of $126.8 billion, Canadian wealth management assets of $92.3 billion, Canadian custody assets of $27.7 billion, and U.S. wealth management assets of $221.2 billion. CI FINANCIAL CORP. April 30, 2024 PRELIMINARY MONTH-END ASSETS (C$ Billions) ENDING ASSETS April 2024 March 2024 % Change April 2023 % Change Asset management (1) $126.8   $130.1   -2.6%   $123.4...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch